Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma
Condition(s):LymphomaLast Updated:November 10, 2021Completed
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:November 10, 2021Completed
Condition(s):Follicular LymphomaLast Updated:July 7, 2023Completed
Condition(s):Lymphoma; Lymphoma CnsLast Updated:June 8, 2023Active, not recruiting
Condition(s):Follicular LymphomaLast Updated:July 16, 2021Terminated
Condition(s):LymphomaLast Updated:January 5, 2024Active, not recruiting
Condition(s):LymphomaLast Updated:February 5, 2024Active, not recruiting
Condition(s):LymphomaLast Updated:May 19, 2016Completed
Condition(s):Follicular LymphomaLast Updated:March 19, 2024Active, not recruiting
Condition(s):LymphomaLast Updated:October 15, 2021Enrolling by invitation
Condition(s):LymphomaLast Updated:March 8, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.